^
    BIOMARKER:

    MET amplification

    i
    Other names: DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase




    Show legend

    Include preclinical:
    Non Small Cell Lung Cancer
    Gastric Cancer
    Renal Cell Carcinoma
    Lung Adenocarcinoma
    Gastric Adenocarcinoma
    Solid Tumor
    Cholangiocarcinoma
    Lung Cancer
    Colorectal Cancer
    Gastroesophageal Cancer
    Glioblastoma
    Sarcoma
    Glioma
    Biliary Tract Cancer
    Gallbladder Cancer
    Hepatocellular Cancer
    Head and Neck Cancer
    Gastroesophageal Junction Adenocarcinoma
    Pancreatic Cancer
    HER2 Positive Breast Cancer
    crizotinib
    savolitinib
    tepotinib
    capmatinib
    TPX-0022
    ABBV-400
    ABN401
    cabozantinib tablet
    REGN5093
    gefitinib + tepotinib
    gefitinib + savolitinib
    bevacizumab + crizotinib
    TQ-B3101
    RG3638
    crizotinib + osimertinib
    SCC244
    BYON3521
    gefitinib + CT053PTSA
    APL-101
    osimertinib + savolitinib
    erlotinib + gefitinib + icotinib
    U3-1402
    HQP8361
    AMG 102
    Immunotherapy
    c-MET inhibitor
    erlotinib
    gefitinib
    cetuximab
    panitumumab
    trastuzumab
    afatinib
    osimertinib
    lorlatinib
    cediranib
    selpercatinib
    osimertinib + HQP8361
    CKD-702
    JNJ-38877605
    SGX523
    savolitinib + capmatinib
    GB263T